Chi Advisors LLC Keros Therapeutics, Inc. Transaction History

Chi Advisors LLC

$203 Million
Q3 2023

A detailed history of Chi Advisors LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Chi Advisors LLC holds 407,633 shares of KROS stock, worth $4.54 Million. This represents 6.41% of its overall portfolio holdings.

Number of Shares

407,633

Previous 402,118 1.37%

Holding current value

$4.54 Million

Previous $16.2 Million 19.57%

% of portfolio

6.41%

Previous 6.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$31.57 - $43.02 $174,108 - $237,255	5,515 Added 1.37%	407,633 $13 Million
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $5.26 Million - $7.2 Million	141,059 Added 54.03%	402,118 $16.2 Million
Q1 2023 May 11, 2023	BUY	$41.44 - $59.32 $1.91 Million - $2.73 Million	46,000 Added 21.39%	261,059 $11.1 Million
Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $585,043 - $767,749	14,830 Added 7.41%	215,059 $10.3 Million
Q3 2022 Nov 09, 2022	BUY	$27.8 - $40.12 $2.69 Million - $3.88 Million	96,800 Added 93.59%	200,229 $7.53 Million
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $1.07 Million - $2.76 Million	41,200 Added 66.21%	103,429 $2.86 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $1.88 Million - $2.65 Million	44,711 Added 255.23%	62,229 $3.38 Million
Q4 2021 Feb 11, 2022	BUY	$36.95 - $62.89 $180,722 - $307,594	4,891 Added 38.73%	17,518 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $3.04 Million - $4.54 Million	-103,779 Reduced 89.15%	12,627 $500,000
Q2 2021 Aug 11, 2021	SELL	$42.4 - $70.11 $12 Million - $19.9 Million	-284,062 Reduced 70.93%	116,406 $4.94 Million
Q1 2021 May 14, 2021	SELL	$54.0 - $75.28 $1.8 Million - $2.51 Million	-33,384 Reduced 7.69%	400,468 $24.6 Million
Q4 2020 Feb 12, 2021	SELL	$36.0 - $82.74 $4.88 Million - $11.2 Million	-135,606 Reduced 23.81%	433,852 $30.6 Million
Q3 2020 Nov 12, 2020	SELL	$27.04 - $62.21 $278,133 - $639,892	-10,286 Reduced 1.77%	569,458 $22 Million
Q2 2020 Aug 12, 2020	BUY	$20.08 - $40.39 $11.6 Million - $23.4 Million	579,744 New	579,744 $21.7 Million

Others Institutions Holding KROS

# of Institutions

173

Shares Held

30.1M

Call Options Held

76.8K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $287M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.

Account